Why the study?
ADHD diagnosis in women has markedly increased, leading to higher ADHD medication exposure during pregnancy with uncertain health risks, making it critical to understand the extent of prescribing.
What is the prevalence of ADHD medication prescribing during pregnancy?
What is the prevalence of ADHD medication prescribing during pregnancy?
The prevalence of ADHD medication prescribing during pregnancy ranges from 0.07 to 6.01 per 1,000 pregnancies, with psychostimulants being the most commonly prescribed.
Answers are grounded in this paper and cite their sources.
ADHD medication dispensing reaches 6/1,000 pregnancies; leaves open critical gaps in fetal safety data requiring prospective study.
Attention deficit hyperactivity disorder (ADHD) diagnosis in women has markedly increased in recent years, resulting in an increase of ADHD medication exposure during pregnancy, which has uncertain health risks. It is therefore critical to understand the extent of the issue. The objective of this novel systematic review was to investigate the prevalence of the prescribing of ADHD medication during pregnancy. A systematic review was conducted following preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. The last search was October 13, 2023, for articles examining the prescribing of ADHD medication in pregnancy. Fifteen studies were included. Participants from the United States (n = 4), the Nordic countries (n = 10), Canada (n = 3), and Australia (n = 1) were included. The prevalence of ADHD-medication dispensing during pregnancy ranged from 0.07 to 6.01 per 1,000 pregnancies. Typically, stimulant medications were more prevalent than nonstimulants. The most prevalent ADHD medication dispensed during pregnancy was methylphenidate followed by amphetamine-type medications. There was high heterogeneity (I2 = 99.95%) between the studies, making the study data not appropriate for meta-analysis. The prevalence of the prescribing of ADHD medications in pregnancy ranged substantially, with psychostimulant medications most prescribed. Apart from in the Nordic countries, estimates of prevalence were limited.
No takes yet. Share an insight, caveat, or question.
Russell et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: